| Safety and activity of anti–PD-L1 antibody in patients with advanced cancer JR Brahmer, SS Tykodi, LQM Chow, WJ Hwu, SL Topalian, P Hwu, ... New England journal of medicine 366 (26), 2455-2465, 2012 | 9208 | 2012 |
| Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer E Sato, SH Olson, J Ahn, B Bundy, H Nishikawa, F Qian, AA Jungbluth, ... Proceedings of the National Academy of Sciences 102 (51), 18538-18543, 2005 | 2936 | 2005 |
| Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer J Matsuzaki, S Gnjatic, P Mhawech-Fauceglia, A Beck, A Miller, T Tsuji, ... Proceedings of the National Academy of Sciences 107 (17), 7875-7880, 2010 | 1038 | 2010 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 824 | 2012 |
| The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin RR Rao, Q Li, K Odunsi, PA Shrikant Immunity 32 (1), 67-78, 2010 | 756 | 2010 |
| Gene expression markers of tumor infiltrating leukocytes P Danaher, S Warren, L Dennis, L D’Amico, A White, ML Disis, MA Geller, ... Journal for immunotherapy of cancer 5, 1-15, 2017 | 724 | 2017 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 662 | 2013 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 589 | 2015 |
| Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ... Journal of the National Cancer Institute 107 (11), djv214, 2015 | 532 | 2015 |
| PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment N Obermajer, R Muthuswamy, K Odunsi, RP Edwards, P Kalinski Cancer research 71 (24), 7463-7470, 2011 | 517 | 2011 |
| Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints ME Mikucki, DT Fisher, J Matsuzaki, JJ Skitzki, NB Gaulin, JB Muhitch, ... Nature communications 6 (1), 7458, 2015 | 508 | 2015 |
| Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013 | 492 | 2013 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 466 | 2017 |
| Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics K Odunsi, RM Wollman, CB Ambrosone, A Hutson, SE McCann, ... International journal of cancer 113 (5), 782-788, 2005 | 463 | 2005 |
| A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis J Shen, CB Ambrosone, RA DiCioccio, K Odunsi, SB Lele, H Zhao Carcinogenesis 29 (10), 1963-1966, 2008 | 441 | 2008 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 427 | 2013 |
| Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism J Liao, F Qian, N Tchabo, P Mhawech-Fauceglia, A Beck, Z Qian, X Wang, ... PloS one 9 (1), e84941, 2014 | 418 | 2014 |
| Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population H Song, E Dicks, SJ Ramus, JP Tyrer, MP Intermaggio, J Hayward, ... Journal of Clinical Oncology 33 (26), 2901-2907, 2015 | 415 | 2015 |
| Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer Y Miyahara, K Odunsi, W Chen, G Peng, J Matsuzaki, RF Wang Proceedings of the National Academy of Sciences 105 (40), 15505-15510, 2008 | 411 | 2008 |
| Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer RY Huang, A Francois, AJR McGray, A Miliotto, K Odunsi Oncoimmunology 6 (1), e1249561, 2017 | 377 | 2017 |
Adam R. KarpfProfessor, Eppley Institute, University of Nebraska Medical CenterOverená e-mailová adresa na: unmc.edu